RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration

Thyroid

Volumn 15, Issue 12, 2005, Pages 1355-1361

  Elisei, Rossella ^a   Romei, Cristina ^a   Castagna, Maria Grazia ^a   Lisi, Simonetta ^a   Vivaldi, Agnese ^a   Faviana, Pinuccia ^a   Marinò, Michele ^a   Ceccarelli, Claudia ^a   Pacini, Furio ^b   Pinchera, Aldo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; MESSENGER RNA; PROTEIN PTC3; PROTEIN RET; THYROGLOBULIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INVASION; CASE REPORT; CLINICAL FEATURE; ECHOGRAPHY; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; OVARY TUMOR; PHYSICAL EXAMINATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TERATOMA; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID FUNCTION; THYROIDECTOMY; THYROTOXICOSIS;

FEMALE; GENE REARRANGEMENT; HUMANS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; OVARIAN NEOPLASMS; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; STRUMA OVARII; THYROGLOBULIN; THYROID GLAND;

EID: 31144432081     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.1355     Document Type: Article

References (28)

1. Livolsi VA. 1990 Thyroid lesions in unusual places. In: Livolsi VA (ed) Surgical Pathology of the Thyroid. WB Saunders Co, Philadelphia, pp. 351-363.
2. Makani S, Kim W, Gaba AR 2004 Struma ovarii with a focus of papillary thyroid cancer: A case report and review of the literature. Gynecol Oncol 94:835-839.
3. Berghella V, Ngadiman S, Rosenberg H, Hoda S, Zuna RE 1997 Malignant struma ovarii. A case report and review of the literature. Gynecol Obstet Invest 43:68-72.
4. LiVolsi VA, LoGerfo P, Feind C 1978 Thyroglobulin in struma ovarii. J Surg Res 25:12-14.
5. Vadmal MS, Smilari TF, Lovecchio JL, Klein IL, Hajdu SI 1997 Diagnosis and treatment of disseminated struma ovarii with malignant transformation. Gynecol Oncol 64:541-546.
6. Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio G 1987 A new oncogene in human thyroid papillary thyroid carcinomas and their lymph-nodal metastases. Nature 328:170-172.
7. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G 2002. Molecular mechanisms of RET activation in human cancer. Ann NY Acad Sci 963:116-121.
8. Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M 2002 Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol 160:247-254.
9. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F 2001 RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-3216.
10. Sadetzki S, Calderon-Margalit R, Modan B, Srivastava S, Tuttle RM 2004 RET/PTC activation in benign and malignant thyroid tumors arising in a population exposed to low-dose external-beam irradiation in childhood. J Clin Endocrinol Metab 89:2281-2289.
11. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED 1997 Pendred syndrome is caused by mutation in a putative sulphate transporter gene (PDS). Nat Genet 17:411-422.
12. Marino M, Lisi S, Pinchera A, Mazzi B, Latrofa F, Sellari-Franceschini S, McCluskey RT, Chiovato L. 2001 Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid 11:177-185.
13. Lisi S, Marino M, Pinchera A, Mazzi B, Di Cosmo C, Sellari-Franceschini S, Chiovato L 2002 Thyroglobulin in orbital tissues from patients with thyroid associated ophthalmopathy: Predominant localization in fibroadipose tissue. Thyroid 12:351-360.
14. Lisi S, Pinchera A, McCluskey RT, Willnow TE, Refetoff S, Marcocci C, Vitti P, Menconi F, Grasso L, Luchetti F, Collins AB, Marino M 2003 Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: A control mechanism for thyroid hormone release. Proc Natl Acad Sci USA 100:14858-14863.
15. Rose PG, Arafah B, Abdul-Karim FW 1998 Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol 70:425-427.
16. Pacini F, Lari R, Mazzeo S, Grasso L, Taddei D, Pinchera A 1985 Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 23:405-11.
17. Feldt-Rasmussen U, Hegedus L, Perrild H, Rasmussen N, Hansen JM 1989 Relationship between serum thyroglobulin, thyroid volume and serum TSH in healthy non-goitrous subjects and the relationship to seasonal variations in iodine intake. Thyroidology 1:115-118.
18. Pacini F, Pinchera A 1999 Serum and tissue thyroglobulin measurement: Clinical applications in thyroid disease. Biochimie 81:463-467.
19. Elisei R, Pinchera A, Romei C, Gryczynska M, Pohl V, Maenhaut C, Fugazzola L, Pacini F 1994 Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: Evidence of TSH-R gene transcript in medullary histotype. J Clin Endocrinol Metab 78:867-871.
20. Mian C, Lacroix L, Alzieu L, Nocera M, Talbot M, Bidart JM, Schlumberger M, Caillou B 2001 Sodium iodide symporter and pendrin expression in human thyroid tissues. Thyroid 11:825-830.
21. Tsukamoto K, Suzuki H, Harada D, Namba A, Abe S, Usami S 2003 Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: A unique spectrum of mutations in Japanese. Eur J Hum Genet 11:916-922.
22. Viglietto G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M, Fusco A 1995 RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11:1207-1210.
23. Takeuchi K, Murata K, Fujita I 2000 Malignant struma ovarii with peritoneal metastasis: Report of two cases. Eur J Gynaecol Oncol 21:260-261.
24. Dardik RB, Dardik M, Westra W, Montz FJ 1999 Malignant struma ovarii: Two case reports and a review of the literature. Gynecol Oncol 73:447-451.
25. Kabukcuoglu F, Baksu A, Yilmaz B, Aktumen A, Evren I 2002 Malignant struma ovarii. Pathol Oncol Res 8:145-147.
26. Smanik PA, Ryu K, Theil KS, Mazzaferri EL, Jhiang SM 1997 Expression, exon-intron organization and chromosome mapping of the human Sodium Iodide symporter. Endocrinol 138:3555-3558.
27. Ringel MD, Ladenson PW, Levine MA 1998 Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messanger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83:4435-4442.
28. Joba W, Spitzweg C, Schriever K, Heufelder AE 1999 Analysis of human Sodium/iodide symporter, thyroid transcription factor-1 and paired-box-protein-8 gene expression in benign thyroid diseases. Thyroid 9:455-466.